Pharmacy

REVOCON Nitoman

Home » Prescription Drugs 14 » REVOCON Nitoman

Tetrabenazine is a drug for the symptomatical treatment of hyperkinetic movement disorder and is marketed under the trade names Nitoman in Canada and Xenazine in New Zealand and some parts of Europe and is also available in the USA as an orphan drug. Tetrabenazine is used as a treatment but not a cure for hyperkinetic disorders[2] such as:Huntington's Disease - specificially the chorea associated with it Tourette's Syndrome and other tic disorders Tardive dyskinesia a serious and sometimes irreversible side effect of long-term use of many antipsychotics mainly typical antipsychotics Hemiballismus spontaneous flinging limb movements due to subthalamic nucleus damage

Buy REVOCON Nitoman and other Prescription Drugs 14 products online at Medstore.

Buy Online at Medstore - Click Here!

About REVOCON Nitoman:

Product Type: Prescription Drugs 14

REVOCON ( Nitoman/Xenamine GENERIC Tetrabenazine )

REVOCON (Nitoman/Xenamine GENERIC Tetrabenazine)

Nitoman/Xenamine GENERIC Tetrabenazine

25 mg Nitoman/Xenamine GENERIC Tetrabenazine REVOCON

View more Prescription Drugs 14

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.